Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian model.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Neurobiology of Aging

• Publication date

  2014-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.neurobiolaging.2014.01.028PMID 24629674
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Alpha-synuclein aggregation involves a bafilomycin A1-sensitive autophagy pathway

  2012cited by this paper
• Mesenchymal Stem Cells Augment Neurogenesis in the Subventricular Zone and Enhance Differentiation of Neural Precursor Cells into Dopaminergic Neurons in the Substantia Nigra of a Parkinsonian Model

  2012cited by this paper
• Alteration of autophagosomal proteins (LC3, GABARAP and GATE-16) in Lewy body disease.

  2011cited by this paper
• Neuroprotective Effect of Human Mesenchymal Stem Cells in an Animal Model of Double Toxin-Induced Multiple System Atrophy Parkinsonism

  2011cited by this paper
• Localization of MAP1-LC3 in Vulnerable Neurons and Lewy Bodies in Brains of Patients With Dementia With Lewy Bodies

  2011cited by this paper
• Chaperone-mediated autophagy: selectivity pays off.

  2010cited by this paper
• Pathogenic Lysosomal Depletion in Parkinson's Disease

  2010cited by this paper
• Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy

  2010cited by this paper
• Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

  2010cited by this paper
• α-Synuclein impairs macroautophagy: implications for Parkinson’s disease

  2010cited by this paper
• Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and Tau: effects on cognitive impairments.

  2010cited by this paper
• Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease.

  2009cited by this paper
• Rapamycin fed late in life extends lifespan in genetically heterogeneous mice

  2009cited by this paper
• Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.

  2009cited by this paper
• Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein.

  2009cited by this paper
• Autophagy fights disease through cellular self-digestion

  2008cited by this paper
• Mitochondrially localized ERK2 regulates mitophagy and autophagic cell stress

  2008cited by this paper
• Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson’s disease

  2008cited by this paper
• Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy.

  2008cited by this paper
• Autophagy in the pathogenesis of disease.

  2008cited by this paper
• Mitochondrial alterations in Parkinson’s disease: new clues

  2008cited by this paper
• Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species

  2007cited by this paper
• Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death.

  2007cited by this paper
• Trehalose, a Novel mTOR-independent Autophagy Enhancer, Accelerates the Clearance of Mutant Huntingtin and α-Synuclein*

  2007cited by this paper
• RNA interference‐mediated knockdown of α‐synuclein protects human dopaminergic neuroblastoma cells from MPP+ toxicity and reduces dopamine transport

  2007cited by this paper
• Down-regulation of α-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson’s disease rat model ☆

  2006cited by this paper
• Mice lacking alpha-synuclein are resistant to mitochondrial toxins.

  2006cited by this paper
• Down-regulation of alpha-synuclein expression can rescue dopaminergic cells from cell death in the substantia nigra of Parkinson's disease rat model.

  2006cited by this paper
• Mesenchymal stem cells as trophic mediators

  2006cited by this paper
• The roles of intracellular protein-degradation pathways in neurodegeneration

  2006cited by this paper
• Loss of autophagy in the central nervous system causes neurodegeneration in mice

  2006cited by this paper
• Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice

  2006cited by this paper
• Heat shock proteins reduce alpha-synuclein aggregation induced by MPP+ in SK-N-SH cells.

  2006cited by this paper
• Heat shock proteins reduce α‐synuclein aggregation induced by MPP+ in SK‐N‐SH cells

  2006cited by this paper
• Molecular pathophysiology of Parkinson's disease.

  2005cited by this paper
• Regulation of Yeast Replicative Life Span by TOR and Sch9 in Response to Nutrients

  2005cited by this paper
• The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span

  2004cited by this paper
• Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of gamma-synuclein, alpha-synuclein and double alpha/gamma-synuclein null mutant mice.

  2004cited by this paper
• Developmental loss and resistance to MPTP toxicity of dopaminergic neurones in substantia nigra pars compacta of γ‐synuclein, α‐synuclein and double α/γ‐synuclein null mutant mice

  2004cited by this paper
• Mice lacking alpha-synuclein have an attenuated loss of striatal dopamine following prolonged chronic MPTP administration.

  2004cited by this paper
• α-Synuclein Is Degraded by Both Autophagy and the Proteasome*

  2003cited by this paper
• A Cell Protective Mechanism in a Murine Model of Parkinson's Disease

  2003cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease.

  2002cited by this paper
• Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP

  2002cited by this paper
• Adult bone marrow stromal cells differentiate into neural cells in vitro.

  2000cited by this paper
• Multilineage potential of adult human mesenchymal stem cells.

  1999cited by this paper
• Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.

  1997cited by this paper

• Mesenchymal stem cells and the central nervous system: historical perspectives and future directions

  2026cites this paper
• Mesenchymal stem cells enhance selective ER-phagy to promote α-synuclein clearance in Parkinson’s disease

  2025cites this paper
• Caloric Restriction Mimetics as Priming Agents of Mesenchymal Stem Cells Secretome to Enhance Regenerative Responses to Parkinson’s Disease

  2025cites this paper
• Mesenchymal Stem Cells in Veterinary Medicine—Still Untapped Potential

  2025cites this paper
• Prevention of medication-related osteonecrosis of the jaw in mice by adipose-derived stem cells associated with activated autophagic flux

  2024cites this paper
• The Potential of Mesenchymal Stem Cells in Treating Spinocerebellar Ataxia: Advances and Future Directions

  2024cites this paper
• Different Levels of Autophagy Activity in Mesenchymal Stem Cells Are Involved in the Progression of Idiopathic Pulmonary Fibrosis

  2024cites this paper
• Role of F-actin-mediated endocytosis and exercise in mitochondrial transplantation in an experimental Parkinson's disease mouse model.

  2023cites this paper
• Dimethyl fumarate ameliorates Parkinsonian pathology by modulating autophagy and apoptosis via Nrf2-TIGAR-LAMP2/Cathepsin D axis.

  2023cites this paper
• Pathological mechanisms of neuroimmune response and multitarget disease-modifying therapies of mesenchymal stem cells in Parkinson’s disease

  2023cites this paper
• Stem Cell Therapy for the Treatment of Parkinson's Disease: What Promise Does it Hold?

  2023cites this paper
• The potential use of mesenchymal stem cells and their exosomes in Parkinson’s disease treatment

  2022cites this paper
• Statins block mammalian target of rapamycin pathway: a possible novel therapeutic strategy for inflammatory, malignant and neurodegenerative diseases

  2022cites this paper
• Priming mesenchymal stem cells with α-synuclein enhances neuroprotective properties through induction of autophagy in Parkinsonian models

  2022cites this paper
• Human Umbilical Cord Mesenchymal Stem Cells Improve Locomotor Function in Parkinson’s Disease Mouse Model Through Regulating Intestinal Microorganisms

  2022cites this paper
• Mesenchymal Stem/Stromal Cells and Their Paracrine Activity—Immunomodulation Mechanisms and How to Influence the Therapeutic Potential

  2022cites this paper
• Alpha-Synuclein Clearance through Inhibiting Akt/mTOR Pathway by Microfluidic Encapsulated Induced Conjunctival MSCs in a Parkinsonian Model

  2022cites this paper
• PTX3 secreted by human adipose-derived stem cells promotes dopaminergic neuron repair in Parkinson's disease via inhibiting apoptosis

  2021cites this paper
• Immunotherapy in PSP

  2021cites this paper
• Potentials of autophagy enhancing natural products in the treatment of Parkinson disease

  2021cites this paper
• Neuroprotective Effects of Microfluidic Encapsulated Induced Conjunctival Mesenchymal Stem Cells Through Autophagy Modulation in a Parkinsonian Model

  2021cites this paper
• Insights of Extracellular Vesicles of Mesenchymal Stem Cells: a Prospective Cell-Free Regenerative Medicine for Neurodegenerative Disorders

  2021cites this paper
• Neuroprotective effects of Wharton’s jelly-derived mesenchymal stem cells on motor deficits due to Parkinson’s disease

  2021cites this paper
• Comparing the Therapeutic Potential of Stem Cells and their Secretory Products in Regenerative Medicine

  2021cites this paper
• Potentials of autophagy enhancing natural products in the treatment of Parkinson disease

  2021cites this paper
• Role of Autophagy in the Maintenance of Stemness in Adult Stem Cells: A Disease-Relevant Mechanism of Action

  2021cites this paper
• Pentraxin 3 secreted by human adipose‐derived stem cells promotes dopaminergic neuron repair in Parkinson's disease via the inhibition of apoptosis

  2021cites this paper
• Priming mesenchymal stem cells with uric acid enhances neuroprotective properties in parkinsonian models

  2021cites this paper
• Autophagy Inhibitor 3-Methyladenine could not Modulate Rotenone Neurotoxicity in Primary Mesencephalic Cell Culture

  2020cites this paper
• Prevention of multiple system atrophy using human bone marrow-derived mesenchymal stem cells by reducing polyamine and cholesterol-induced neural damages

  2020cites this paper
• Insulin-producing cells from mesenchymal stromal cells: Protection against cognitive impairment in diabetic rats depends upon implant site.

  2020cites this paper
• Mesenchymal stem cells in neurodegenerative diseases: Opinion review on ethical dilemmas.

  2020cites this paper
• Immunotherapy in progressive supranuclear palsy.

  2020cites this paper
• Immunotherapy in progressive supranuclear palsy.

  2020cites this paper
• Mesenchymal stem cells modulate misfolded α-synuclein in parkinsonian disorders: A multitarget disease-modifying strategy.

  2020cites this paper
• Human umbilical cord MSC-derived hepatocyte growth factor enhances autophagy in AOPP-treated HK-2 cells

  2020cites this paper
• Mesenchymal stromal cells (MSCs) for neurodegenerative disease: A promising frontier.

  2020cites this paper
• Mesenchymal Stromal Cells Suppress Hippocampal Neuron Autophagy Stress Induced by Hypoxic-Ischemic Brain Damage: The Possible Role of Endogenous IL-6 Secretion

  2020cites this paper
• Transplanted Wharton`s jelly mesenchymal stem cells improve memory and brain hippocampal electrophysiology in rat model of Parkinson's disease.

  2020cites this paper
• Introduction and Basic Concepts in Stem Cell Research and Therapy: The Facts and the Hype

  2020cites this paper
• Phase I Trial of Intra-arterial Administration of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Multiple System Atrophy

  2020cites this paper
• Mesenchymal stem cell transplantation and aerobic exercise for Parkinson’s disease: therapeutic assets beyond the motor domain

  2019cites this paper
• Olfactory mucosa stem cells: An available candidate for the treatment of the Parkinson's disease

  2019cites this paper
• MPP+ decreases store-operated calcium entry and TRPC1 expression in Mesenchymal Stem Cell derived dopaminergic neurons

  2018cites this paper
• Adipose‐derived stem cells reduce liver oxidative stress and autophagy induced by ischemia‐reperfusion and hepatectomy injury in swine

  2018cites this paper
• Therapy With Mesenchymal Stem Cells in Parkinson Disease: History and Perspectives

  2018cites this paper
• Bone marrow mesenchymal stem cells protect against n-hexane-induced neuropathy through beclin 1-independent inhibition of autophagy

  2018cites this paper
• Iron(III)-Tannic Molecular Nanoparticles Enhance Autophagy effect and T1 MRI Contrast in Liver Cell Lines

  2018cites this paper
• Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease.

  2017cites this paper
• Bone marrow stromal stem cells induce autophagy that may exert neuroprotective effects

  2017cites this paper
• Feasibility and Efficacy of Intra‐Arterial Administration of Mesenchymal Stem Cells in an Animal Model of Double Toxin‐Induced Multiple System Atrophy

  2017cites this paper
• Autophagic modulation by rosuvastatin prevents rotenone-induced neurotoxicity in an in vitro model of Parkinson's disease.

  2017cites this paper
• Concise Review: Mesenchymal Stem Cells in Neurodegenerative Diseases

  2017cites this paper
• Mesenchymal Stem Cells Stabilize Axonal Transports for Autophagic Clearance of α‐Synuclein in Parkinsonian Models

  2017cites this paper
• Neuroprotective effects of Kukoamine A on neurotoxin‐induced Parkinson's model through apoptosis inhibition and autophagy enhancement

  2017cites this paper
• Autophagy: A new treatment strategy for MSC-based therapy in acute kidney injury (Review).

  2017cites this paper
• Mesenchymal stem cells protect neurons against hypoxic-ischemic injury via inhibiting parthanatos, necroptosis, and apoptosis, but not autophagy

  2016cites this paper
• Mesenchymal Stem Cells Inhibit Transmission of α-Synuclein by Modulating Clathrin-Mediated Endocytosis in a Parkinsonian Model.

  2016cites this paper
• Autophagy in acute brain injury

  2016cites this paper
• The Cleavage Effect of Mesenchymal Stem Cell and Its Derived Matrix Metalloproteinase‐2 on Extracellular α‐Synuclein Aggregates in Parkinsonian Models

  2016cites this paper
• Improving Neuro-Regeneration Efficiency in the Stem Cell Treatments of Parkinson’s Disease: Fetal Tissue vs. Mesenchymal Stem Cell

  2016cites this paper
• Rapamycin protects dopaminergic neurons against rotenone-induced cell death in primary mesencephalic cell culture.

  2015cites this paper
• The E3 ubiquitin ligase seven in absentia homolog 1 may be a potential new therapeutic target for Parkinson's disease

  2015cites this paper
• Dopaminergic differentiation of stem cells from human deciduous teeth and their therapeutic benefits for Parkinsonian rats.

  2015cites this paper
• Therapeutic potentials of human adipose-derived stem cells on the mouse model of Parkinson's disease.

  2015cites this paper
• Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects

  2015cites this paper
• Deconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purpose

  2015cites this paper
• Interactions between Autophagy and Bacterial Toxins: Targets for Therapy?

  2015cites this paper
• In vivo imaging and evaluation of therapeutic effect of the neural stem cell treatment in 6-OHDA induced mouse model of Parkinson’s disease

  2015cites this paper
• Control of Autophagy in Parkinson’s Disease

  2015cites this paper
• Recent advances in

  2015cites this paper
• Estrogen Selectively Mobilizes Neural Stem Cells in the Third Ventricle Stem Cell Niche of Postnatal Day 21 Rats

  2015cites this paper
• Recent advances in autophagy-based neuroprotection

  2015cites this paper
• Image Guidance in Stem Cell Therapeutics: Unfolding the Blindfold.

  2014cites this paper
• Mesenchymal stem cells and hypoxia: where are we?

  2014cites this paper